These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18187570)

  • 1. CD30-induced signaling is absent in Hodgkin's cells but present in anaplastic large cell lymphoma cells.
    Hirsch B; Hummel M; Bentink S; Fouladi F; Spang R; Zollinger R; Stein H; Dürkop H
    Am J Pathol; 2008 Feb; 172(2):510-20. PubMed ID: 18187570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells.
    Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z
    Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA expression patterns indicate CD30 mediated activation of different apoptosis pathways in anaplastic large cell lymphoma but not in Hodgkin's lymphoma.
    Staber PB; Noehammer C; Dürkop H; Schauer S; Kenner L; Linkesch W; Hoefler G
    Leuk Res; 2006 Mar; 30(3):343-8. PubMed ID: 16198418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.
    Willenbrock K; Küppers R; Renné C; Brune V; Eckerle S; Weidmann E; Bräuninger A; Hansmann ML
    Haematologica; 2006 May; 91(5):596-604. PubMed ID: 16670065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The restricted expression pattern of the Hodgkin's lymphoma-associated cytokine receptor CD30 is regulated by a minimal promoter.
    Dürkop H; Oberbarnscheidt M; Latza U; Bulfone-Paus S; Hirsch B; Pohl T; Krause H; Hummel M; Stein H
    J Pathol; 2000 Oct; 192(2):182-93. PubMed ID: 11004694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CD30 gene promoter microsatellite binds transcription factor Yin Yang 1 (YY1) and shows genetic instability in anaplastic large cell lymphoma.
    Franchina M; Woo AJ; Dods J; Karimi M; Ho D; Watanabe T; Spagnolo DV; Abraham LJ
    J Pathol; 2008 Jan; 214(1):65-74. PubMed ID: 17973241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JunB induced by constitutive CD30-extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase signaling activates the CD30 promoter in anaplastic large cell lymphoma and reed-sternberg cells of Hodgkin lymphoma.
    Watanabe M; Sasaki M; Itoh K; Higashihara M; Umezawa K; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Cancer Res; 2005 Sep; 65(17):7628-34. PubMed ID: 16140928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells.
    Horie R; Watanabe T; Morishita Y; Ito K; Ishida T; Kanegae Y; Saito I; Higashihara M; Mori S; Kadin ME; Watanabe T
    Oncogene; 2002 Apr; 21(16):2493-503. PubMed ID: 11971184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of CD30 in anaplastic large cell lymphoma is regulated by nucleophosmin-anaplastic lymphoma kinase-mediated JunB level in a cell type-specific manner.
    Hsu FY; Johnston PB; Burke KA; Zhao Y
    Cancer Res; 2006 Sep; 66(18):9002-8. PubMed ID: 16982741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD30-mediated cell cycle arrest associated with induced expression of p21(CIP1/WAF1) in the anaplastic large cell lymphoma cell line Karpas 299.
    Hübinger G; Müller E; Scheffrahn I; Schneider C; Hildt E; Singer BB; Sigg I; Graf J; Bergmann L
    Oncogene; 2001 Feb; 20(5):590-8. PubMed ID: 11313991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 ligation induces nuclear factor-kappa B activation in human T cell lines.
    McDonald PP; Cassatella MA; Bald A; Maggi E; Romagnani S; Gruss HJ; Pizzolo G
    Eur J Immunol; 1995 Oct; 25(10):2870-6. PubMed ID: 7589085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30 ligand signal transduction involves activation of a tyrosine kinase and of mitogen-activated protein kinase in a Hodgkin's lymphoma cell line.
    Wendtner CM; Schmitt B; Gruss HJ; Druker BJ; Emmerich B; Goodwin RG; Hallek M
    Cancer Res; 1995 Sep; 55(18):4157-61. PubMed ID: 7545087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
    Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
    Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of thymus and activation regulated chemokine and its receptor CCR4 in nodal and cutaneous anaplastic large-cell lymphomas and Hodgkin's disease.
    Vermeer MH; Dukers DF; ten Berge RL; Bloemena E; Wu L; Vos W; de Vries E; Tensen CP; Meijer CJ; Willemze R
    Mod Pathol; 2002 Aug; 15(8):838-44. PubMed ID: 12181269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
    Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
    Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression and function of A20 and TRAF1 in Hodgkin lymphoma and anaplastic large cell lymphoma and their induction by CD30 stimulation.
    Dürkop H; Hirsch B; Hahn C; Foss HD; Stein H
    J Pathol; 2003 Jun; 200(2):229-39. PubMed ID: 12754742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of IκB-ζ by Epstein-Barr virus latent membrane protein-1 and CD30.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2015 Dec; 47(6):2197-207. PubMed ID: 26498461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AP-1 mediated relief of repressive activity of the CD30 promoter microsatellite in Hodgkin and Reed-Sternberg cells.
    Watanabe M; Ogawa Y; Ito K; Higashihara M; Kadin ME; Abraham LJ; Watanabe T; Horie R
    Am J Pathol; 2003 Aug; 163(2):633-41. PubMed ID: 12875982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.